mercoledì 4 marzo 2015

Edoardo Cignoli : FDA Approves Bristol-Myers Drug for Lung Cancer

U.S. regulators approved Bristol-Myers Squibb’s advanced lung cancer drug Opdivo, ithe latest of a string of events that has the oncology world riveted on efforts to enlist the body’s immune system to fight the disease.



via WSJ.com: US Business http://ift.tt/1NiJHaa

Nessun commento:

Posta un commento